- Home
- J&J Innovative Medicine
J&J Innovative Medicine
A vaccine for E. coli? Meet a researcher hot on the trail
A particular strain of the bacteria can be deadly for those over the age of 60—and it’s not the kind that causes food poisoning. But this Janssen researcher is committed to finding a preventive treatment.
What you need to know about Johnson & Johnson’s 2019 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
From Aha! moment to FDA approval: The fascinating story behind a new treatment for bladder cancer
For National Cancer Prevention Month, we retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of bladder cancer to patients who may benefit most.
“I had four strokes and two brain surgeries—and survived”
Lisa Deck was just 21 when she had her first stroke. She would go on to have three more, as well as face a rare diagnosis of moyamoya disease. For World Stroke Day, we’re sharing her incredible story of survival and living with a chronic illness.
How Johnson & Johnson is helping tackle a devastating tropical disease that impacts kids
A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.
5 things to know about the 2018 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.
He beat childhood cancer. Now he’s trying to save lives as a cancer researcher
Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For National Cancer Survivor Month, we share his incredible story.
Lung cancer: What you need to know about your risk factor—even if you’ve never smoked
Some 20% of people diagnosed with the disease haven’t touched a cigarette. For Healthy Lung Month, scientists who’ve dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
Johnson & Johnson named a 2019 Fortune World’s Most Admired Company
The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.
What you need to know about Johnson & Johnson’s 2018 full-year earnings report
Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year.